Condor Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-7,947
| Closed | -$428K | – | 194 |
|
|
2015
Q4 | $428K | Sell |
7,947
-369
| -4% | -$19.9K | 0.1% | 138 |
|
|
2015
Q3 | $410K | Sell |
8,316
-12
| -0.1% | -$592 | 0.11% | 144 |
|
|
2015
Q2 | $485K | Sell |
8,328
-387
| -4% | -$22.5K | 0.12% | 143 |
|
|
2015
Q1 | $501K | Buy |
8,715
+2,091
| +32% | +$120K | 0.12% | 144 |
|
|
2014
Q4 | $334K | Sell |
6,624
-120
| -2% | -$6.05K | 0.09% | 142 |
|
|
2014
Q3 | $316K | Sell |
6,744
-39
| -0.6% | -$1.83K | 0.09% | 139 |
|
|
2014
Q2 | $305K | Buy |
+6,783
| New | +$305K | 0.09% | 139 |
|
|
2013
Q4 | – | Sell |
-7,368
| Closed | -$261K | – | 161 |
|
|
2013
Q3 | $261K | Buy |
7,368
+78
| +1% | +$2.76K | 0.09% | 140 |
|
|
2013
Q2 | $242K | Buy |
+7,290
| New | +$242K | 0.09% | 145 |
|